Suggest you read the ANN again... bottom of Pg 3:
And top of Pg 4:
What I noticed was "preferred potential off-take customer(s)". Note the use of potentially more then one!
IMO, JZ knows how to play hardball and knows AGY have a highly desirable product in a sector experiencing short supply.
Also IMO, if you're buying BG LCE, I expect you'd not only want to lab test it's composition but also plug it into your systems (ie "systemised" in below extract) and produce an output that is then in turn QA'd by their customers (no one wants a battery that malfunctions!). And you don't want to just do this once, but several times to prove consistency and reliability of both the inputs and outputs of the production line. So the take away message for me is this is well progressed but does take time.
(And not to mention - a "preferred" off-take customer doesn't take this time and effort unless they are serious about buying your product!)
Top of Page 9:
- Forums
- ASX - By Stock
- AGY
- Ann: Quarterly Activities Report - September 2018
Ann: Quarterly Activities Report - September 2018, page-89
-
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $362.9K | 4.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 93664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 0.085 |
3 | 99873 | 0.084 |
4 | 169062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 93664 | 1 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
0.091 | 52101 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online